CCN2 and Hepatic fibrosis: So far, we have demonstrated that hepatocyte ChREBPα antagonizes the TGFβ‐E2F1‐driven THBS1 and CTGF expression, leading us to speculate that depletion of hepatic E2f1 might reverse HSCs activation and liver fibrosis in Chrebpα‐LKO mice.